First Graphene shares updates on its quarterly activities

First Graphene has provided an update on its  financial and operational performance for the quarter ending 30 June 2025.

First Graphene reported a combined income for the June quarter of FY2025 of circa A$273,000 (almost US$177,000) - unaudited, comprised of ~A$145,000 (US$93,700) in graphene sales and ~A$128,000 (US$83,000) in paid development and grant-funded programs. The graphene sales revenue was primarily generated from the composites and polymer segments. This brings total income for FY2025 (unaudited) to more than A$1.2 million *us$776,000), covering topline graphene sales, development and grant-funded programs.

 

First Graphene’s pipeline of commercial opportunities started to convert during the quarter, with the receipt of two significant material orders totaling ~A$165,000 (US$106,700) for PureGRAPH® materials to be used in polymers.

First Graphene also secured a deal for graphene-enhanced safety boots for mining. The exclusive deal with Indonesian manufacturer PT Alasmas Berkat Utama will result in more than two and a half tonnes of PureGRAPH® 10 masterbatch being used over the first two years to develop the footwear.

First Graphene has successfully completed its technical development program for a graphene-based cement additive, with positive results demonstrating commercial readiness. Rigorous field and production-scale trials, including more than 1000 tonnes of graphene enhanced cement produced in partnership with Breedon at the UK’s largest cement plant, reportedly confirmed the additive’s effectiveness in real-world applications.

The Company also made a significant breakthrough in the dispersion of graphene within cement systems, achieving a stable, reproducible and industrially scalable formulation through its PureGRAPH-CEM® product line. 

First Graphene is now focused on accelerating commercial penetration through scale-up projects with
end users and global cement producers.  

The Company is executing its Development and Commercialization Agreement with Breedon and pursuing strategic trials across Europe, Southeast Asia, New Zealand and Australia. These initiatives, alongside recent product trademark grants and manufacturing scale achievements, mark significant advances in First Graphene’s commercial strategy for the cement and concrete industry.

The Company is is also working on additional cement trials in the UK and South Africa, such as its collaborative trial with England-based fine chemical manufacturer Lianhetech Seal Sands to develop PureGRAPH® enhanced repair mortar and a concrete slab trial used in a large-scale fire testing
project by Stellenbosch University, Glade Chemicals, AFRIMAT and Kindling Inc. in South Africa

First Graphene also commenced testing of both PureGRAPH® and graphene materials provided by Australian Sunlight Group during the quarter as part of the cross-sector A$3.72 million HyPStore project. The project aims to develop and commercialize lightweight, impermeable cryogenic tanks designed for
the storage and transportation of liquid hydrogen.

In addition, the Company’s strategic partner Senergy Innovations (Senergy) has launched nine industry-ready products into a variety of commercial markets covering the automotive, industrial and energy sectors. First Graphene supplies PureGRAPH® for use in Senergy’s products, including thermally conductive
polymers used to harness sunlight for water heating systems. The launch marks a big step forward for the partnership between First Graphene and Senergy as it enters commercialization of the versatile range of performance-enhancing products.

Various other updates were also mentioned in the report, such as:

  •  a 10-month project to upscale chemically modified graphene for 3D printing of metal components, in collaboration with Imperial College London and University College London.  
  • 2D Fluidics Pty Ltd was voluntarily deregistered and is no longer a subsidiary of First Graphene Limited, after its technology was determined to be commercially unfeasible.


 

Posted: Aug 02,2025 by Roni Peleg